Sunny Balwani and the Theranos saga’s final chapter

Sunny Balwani, Elizabeth Holmes’s former lover and business partner, has been convicted for his role in the building of a multibillion-dollar fraud at Theranos

Nearly eight years after serious concerns were raised about Theranos’s blood-testing technology, the final chapter of the legal saga has closed. Following a 13-week trial, Ramesh "Sunny" Balwani, the former lover and business partner of Theranos founder Elizabeth Holmes, has been convicted on all 12 fraud charges brought against him (compared with Holmes’s four counts) – including a charge of “defrauding patients” that Holmes escaped when convicted in January. “Defence attorneys depicted Balwani as a loyal soldier” who had “tried to save the company,” which, at its height, was worth $9bn, says The Guardian. The jury was having none of it.

A clear vision

The Theranos scandal isn’t just the story of a company whose false claim to have revolutionised medicine gulled everyone from former US secretaries of state George Shultz and Henry Kissinger (who lent their weight to the board) to big-name investors such as Rupert Murdoch and tech mogul Larry Ellison.

It also charts the course of an ultimately toxic love affair. According to Bad Blood – the account of the saga by John Carreyrou, the Wall Street Journal reporter who first broke the story – Holmes and Balwani met in 2002, when she was 18 and he was 37, during a summer trip to Beijing organised by Stanford University’s Mandarin programme. She had been bullied by other students. “Sunny, the lone adult among a group of college kids, had stepped in and come to her aid.” The two became fast friends and, a year after Holmes dropped out of Stanford to found Theranos in 2004, began living together. In 2009, Balwani joined the company as its president and COO, sealing a relationship that went from platonic, to romantic, to strategic within a few short years.

Balwani once told Fortune he had been attracted by Holmes’s “clear vision” for the company, based on a fingerstick device that could purportedly detect hundreds of diseases from a few drops of blood. She, in turn, was impressed by his CV – and perhaps his cash, says Vanity Fair. “I understood that he’d been a really successful business person, that he worked with Bill Gates in the early days of Microsoft,” she said at her trial. Born to a Hindu family in Pakistan, and raised in India, Sunny enrolled at the University of Texas in 1986 after his family moved to the US. After stints as a software engineer at Lotus and Microsoft, he successfully rode the dotcom boom – co-founding CommerceBid.com (which aided companies trading over the internet), “cashing out for nearly $40m” before the company went bust.

“We will transcend!”

Holmes and Balwani “went to elaborate lengths” to keep their 12-year relationship a secret while running Theranos, says Vanity Fair. It wasn’t the “largest lie” they told in “their troublesome quest” to build a multibillion-dollar business, but would certainly have been flagged up as a conflict of interest by investors.

Many employees weren’t fooled, says Yahoo News. Carreyrou relates that one of his early sources at the company “painted the portrait of this fraud being run by a couple”. That source also alleged that Balwani was an uncomfortably controlling boss, allegedly “terrorising everyone” by keeping track of them through security footage. A later HBO documentary showed leaked footage of him leading employees in a “F*** you” chant, aimed at Theranos’s enemies and competitors.

We will never know the full truth about the pair’s relationship, says The Information. But recent interviews with those who knew Balwani shed light on “an ambitious, canny and street-smart man…eager to leave a big mark in America, and convinced that his destiny, and that of Holmes, were spiritually ordained”. As he once wrote to her, “We will transcend!” Both now face a possible 20 years in jail.

Recommended

Are GSK’s legal troubles a threat to the firm’s survival?
Biotech stocks

Are GSK’s legal troubles a threat to the firm’s survival?

Pharmaceutical giant GlaxoSmithKline is facing legal action over heartburn drug Zantac that has seen billions wiped off its market value. Rupert Hargr…
16 Aug 2022
How to cut the cost of living
Personal finance

How to cut the cost of living

Culling your direct debits, lowering your boiler’s temperature and signing up for loyalty cards are all strategies to help combat the rising cost of l…
16 Aug 2022
A South African adventure
Travel and holidays

A South African adventure

From buzzy Johannesburg to big game drives, South Africa has it all, says Katie Monk
16 Aug 2022
Investors should get ready for a political revolution
UK Economy

Investors should get ready for a political revolution

Liz Truss will beat Rishi Sunak, cut taxes, and then shake up the Bank of England, says Helen Thomas
15 Aug 2022

Most Popular

Don’t listen to the doom-mongers – the future is bright
Economy

Don’t listen to the doom-mongers – the future is bright

With volatile markets, raging inflation and industrial unrest, it may feel like things are bad and likely to get worse. But the end of the world is no…
15 Aug 2022
Are UK house prices set to fall? It’s not so simple
House prices

Are UK house prices set to fall? It’s not so simple

Figures suggest UK house prices are starting to slide, but we shouldn’t take these numbers at face value, explains Rupert Hargreaves.
11 Aug 2022
How solar panels could lower your energy bill
Energy

How solar panels could lower your energy bill

Solar-panel installation firms are reporting a four-fold increase in orders this year compared with 2021. Ruth Jackson-Kirby explains how solar can he…
14 Aug 2022